The number of EpiPens could run out in August, according to an update from Health Canada.
The feds had warned about a looming shortage, and a news release said, “Pfizer Canada has advised Health Canada that supply of EpiPen in the 0.3 mg format is expected to be very limited at pharmacies during the month of August. This means that while some pharmacies may currently have some inventory on-hand, it will likely be depleted in the coming days or weeks.”
The company will be unable to replenish the supply until the end of August, said the news release, adding that the company has also advised that, at this time, they continue to be able to supply EpiPen Jr (0.15 mg); however, the supply is limited and is being carefully managed at the national level.”
EpiPen and EpiPen Jr deliver an emergency treatment of adrenaline (epinephrine) to patients who are at risk of life-threatening allergic reactions (anaphylaxis). There are no other types of auto-injectors available in Canada.
“Pfizer Canada informed Health Canada that the current shortage is due to a manufacturing issue with the EpiPen 0.3 mg format,” said the news release. “Canadians are encouraged to visit drugshortagescanada.ca or contact Pfizer Canada directly for up-to-date information about the shortage and estimated re-supply dates.”